Delaware Board of Pharmacy Regulations: Navigating Telehealth Prescribing, Compounding, and Medication Fulfillment

Operating a telehealth practice or any healthcare business that involves prescribing and dispensing medications in Delaware requires a comprehensive understanding of the state's Board of Pharmacy regulations. These rules establish the framework for legitimate prescription practices, compounding standards, and the responsible fulfillment of medications, directly impacting telehealth providers, medspas, dental practices, and chiropractors.

The Role of the Delaware Board of Pharmacy

The Delaware Board of Pharmacy, under the Division of Professional Regulation, is responsible for regulating the practice of pharmacy within the state. Its mission is to protect the public health, safety, and welfare by ensuring that all pharmacists, pharmacies, and pharmacy technicians meet the highest standards of practice. This oversight extends to how prescriptions are generated, verified, compounded, and dispensed, regardless of whether the originating consultation was in-person or via telehealth.

Telehealth Prescribing Requirements

Delaware law recognizes the validity of prescriptions issued via telehealth, provided they meet the same standards as in-person prescriptions. The core principle is that a valid prescriber-patient relationship must be established. While Delaware has adopted a flexible approach to telehealth, the prescriber must still conduct an appropriate evaluation, establish a diagnosis, and maintain proper medical records. Pharmacists have a corresponding responsibility to ensure that prescriptions are issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice. This includes verifying the legitimacy of telehealth-originated prescriptions.

Key considerations for telehealth prescribing in Delaware include:

• Established Prescriber-Patient Relationship: A prescription issued via telehealth must stem from a legitimate medical evaluation. While the specific method of evaluation can be remote, it must be sufficient to meet the standard of care. Delaware's Medical Board regulations (24 Del. C. § 1702(12)) define the practice of medicine to include diagnosis and treatment, which can occur through telehealth.
• Prescribing Controlled Substances: Prescribing controlled substances via telehealth in Delaware generally aligns with federal DEA requirements. While the federal Public Health Emergency (PHE) has provided temporary waivers allowing for prescribing controlled substances without an initial in-person visit, providers must remain vigilant about the evolving federal landscape and ensure compliance with any specific Delaware state requirements that may apply post-PHE.
• Pharmacist's Corresponding Responsibility: Delaware pharmacists are obligated to exercise professional judgment when dispensing prescriptions. This includes questioning prescriptions that appear questionable or lack a legitimate medical purpose, even if they originate from a telehealth encounter. Telehealth providers should ensure their prescriptions are clear, complete, and easily verifiable to avoid delays or rejections.

Compounding Regulations

Compounding pharmacies play a crucial role in providing customized medications, and their activities are strictly regulated by the Delaware Board of Pharmacy. These regulations apply to both in-state pharmacies and out-of-state pharmacies that compound and dispense medications for Delaware patients.

Delaware's compounding regulations largely align with federal standards set by the U.S. Pharmacopeia (USP), specifically USP General Chapter <795> for non-sterile compounding and USP General Chapter <797> for sterile compounding. Key aspects include:

• Patient-Specific Prescriptions: Compounded medications must be prepared for an individual patient based on a valid prescription. Compounding for